Industry News

Industry News

Patients With AL Amyloidosis May Benefit From Powerful Myeloma Treatment Regimen

Feb 15, 2012

Two studies published in Blood, the Journal of the American Society of Hematology (ASH), demonstrate preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis, a rare and devastating blood disease that results in deposition of damaging abnormal protein in critical organs of the body, including the kidneys, heart, liver, and intestines, an... Read More

Orgasms Often Unafffected Following Nerve Sparing In Prostate Cancer Surgery

Feb 15, 2012

The vast majority of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing the nerves that surround the prostate gland like a hammock, according to a study in the February issue of the urology journal BJUI... Read More

Targeting Leukemia Stem Cells

Feb 15, 2012

New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse... Read More

Quest For Cancer Treatments Strengthened By Cell Discovery

Feb 15, 2012

Fresh insights into how our cells multiply could help scientists develop drugs to treat cancer. Researchers have gained better understanding of the workings of two key proteins that control cell division. This process must be carried out accurately to keep cells healthy, and when it goes out of control, it can lead to cancer... Read More

Ingestion Of PAHs From Pavement Sealant May Put Children At Risk

Feb 15, 2012

Children living near coal-tar-sealed pavement are likely to receive a far higher dose of carcinogenic polycyclic aromatic hydrocarbons (PAHs) from incidental ingestion of house dust than do children living near unsealed pavement, and that dose is more than two times higher than the PAH dose children are estimated to receive from food... Read More

Human Testing Of New HIV-Vaccine

Feb 15, 2012

Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were 'so to say' vaccinated with their own cells. The researchers filtered certain white blood cells out of the volunteer's blood, 'loaded' them outside the body and then gave them back... Read More

Orgasms Often Unafffected Following Nerve Sparing In Prostate Cancer Surgery

Feb 15, 2012

The vast majority of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing the nerves that surround the prostate gland like a hammock, according to a study in the February issue of the urology journal BJUI... Read More

Targeting Leukemia Stem Cells

Feb 15, 2012

New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse... Read More

Breast Cancer Spreads By Using Patient's Immune System

Feb 14, 2012

Inflammatory breast cancer (IBC) spreads easily through the lymphatic and blood vessels, forming metastasis, which can cause several organs in the body to fail, IBC is also the deadliest form of breast cancer... Read More

News From The Journal Of Clinical Investigation: Feb. 13, 2012

Feb 14, 2012

METABOLIC DISEASE: A direct hit from the hormone leptin has potential therapeutic consequences The number of people who suffer from one or more of the adverse complications of obesity, including type 2 diabetes, is rapidly increasing. The hormone leptin decreases food intake and increases energy expenditure. As such, it was hoped that it could be developed as an anti-obesity agent... Read More

Previous Page   Next Page